ArticleMultiple sclerosis and related disorders2022

Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod.

Magdalena Krbot Skorić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.